SHA:688578 Revenue

Shanghai Allist Pharmaceuticals had revenue of 1.28 billion CNY in the quarter ending June 30, 2025, with 52.99% growth. This brings the company's revenue in the last twelve months to 4.36 billion, up 53.03% year-over-year. In the year 2024, Shanghai Allist Pharmaceuticals had annual revenue of 3.56 billion with 76.29% growth.

Revenue (ttm)

4.36B

Revenue Growth

+53.03%

P/S Ratio

10.68

Revenue / Employee

2.39M

Employees

1,417

Market Cap

46.51B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	3.56B	1.54B	76.29%
Dec 31, 2023	2.02B	1.23B	155.14%
Dec 31, 2022	791.00M	260.91M	49.22%
Dec 31, 2021	530.09M	529.53M	94,409.97%
Dec 31, 2020	560.89K	-68.84K	-10.93%
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Huadong Medicine	42.62B
WuXi AppTec	41.90B
Yunnan Baiyao Group Co.,Ltd	40.84B
Shanghai Fosun Pharmaceutical (Group)	40.12B
Shenzhen Mindray Bio-Medical Electronics	32.94B
Jiangsu Hengrui Medicine	30.15B
Zhejiang NHU Company	22.87B
Aier Eye Hospital Group	21.94B

Revenue Rankings